Best strategies That Can Drive you on this: Kamada Ltd. (NASDAQ: KMDA)
Kamada Ltd. stock identified change of 40.38% away from 52-week low price and recently located move of -13.88% off 52-week high price. KMDA stock has been recorded 2.73% away from 50 day moving average and 18.22% away from 200 day moving average. Moving closer, we can see that shares have been trading 3.52% off 20-day moving average. Kamada Ltd. noticed change of 0.58% to $6.89 along volume of 129439 shares in recent session compared to an average volume of 66.59K.
Kamada Ltd. (KMDA) recently reported financial results for the three months and nine months ended September 30, 2019.
“We are happy with our continued strong performance in the third quarter and year-to-date 2019,” stated Amir London, Kamada’s Chief Executive Officer. “For the third quarter of 2019, total revenues were $33.1M, a 121% increase contrast to the third quarter of 2018, which, as a reminder, was negatively influenced by our manufacturing facility labor strike. For the first nine months of 2019, total revenues were $95.1M, representing a 44% increase over the first nine months of 2018. Based on our continued strong performance in the third quarter, and our positive outlook for the fourth quarter of the year, we expect to achieve our full-year 2019 total revenue guidance of $125M to $130M.”
Financial Highlights for the Three Months Ended September 30, 2019
Total revenues were $33.1M in the third quarter of 2019, a 121% increase from the $15.0M recorded in the third quarter of 2018. As a reminder, Kamada’s third quarter 2018 financial results were influenced by the then labor strike in the Company’s manufacturing facility
Revenues from the Proprietary Products section in the third quarter of 2019 were $24.9M, a 163% increase from the $9.5M stated in the third quarter of 2018
Revenues from the Distribution section were $8.2M in the third quarter of 2019, a 49% increase from the $5.5M recorded in the third quarter of 2018
Gross profit was $12.9M in the third quarter of 2019, a 411% increase from the $2.5M stated in the third quarter of 2018. Gross margin increased to 39% from 17% in the third quarter of 2018
Operating expenses, including R&D, Sales & Marketing, G&A, and Other expenses, totaled $7.2M in the third quarter of 2019, as contrast to $5.0M in the third quarter of 2018. As Kamada is in the process of initiating its Inhaled AAT Phase 3 clinical and the first patient in the trial is predictable to be enrolled before the end of the year. The Company continues to expect that its annual R&D expenses will increase for full-year 2019 as contrast to 2018
Net income was $5.8M or $0.14 per share, in the third quarter of 2019, as contrast to a net loss of $2.4M, or ($0.06) per share, in the third quarter of 2018
Adjusted EBITDA, as detailed in the tables below, was $7.2M in the third quarter of 2019, as contrast to ($1.4)M in the third quarter of 2018
Cash provided by operating activities was $6.1M in the third quarter of 2019, as contrast to cash provided by operating activities of $1.0M in the third quarter of 2018
Financial Highlights for the Nine Months Ended September 30, 2019
Total revenues were $95.1M in the first nine months of 2019, a 44% increase from the $66.3M recorded in the first nine months of 2018. As a reminder, Kamada’s financial results for the nine months ended September 30, 2018, were influenced by the third quarter 2018 labor strike in the Company’s manufacturing facility
Revenues from the Proprietary Products section for the first nine months of 2019 were $72.5M, a 52% increase from the $47.6M stated in the first nine months of 2018
Revenues from the Distribution section were $22.6M in the first nine months of 2019, a 21% increase from the $18.6M recorded in the first nine months of 2018
Gross profit was $37.6M in the first nine months of 2019, an 86% increase from the $20.2M stated in the first nine months of 2018. Gross margin increased to 40% from 31% in the first nine months of 2018
Operating expenses, including R&D, Sales & Marketing and G&A, and Other expenses, totaled $20.3M in the first nine months of 2019, as contrast to $16.3M in the first nine months of 2018
Net income was $16.9M, or $0.42 per share, in the first nine months of 2019, as contrast to net income of $4.6M, or $0.11 per share, in the first nine months of 2018
Adjusted EBITDA, as detailed in the tables below, was $21.6M in the first nine months of 2019, as contrast to $7.4M in the first nine months of 2018
Cash provided by operating activities was $18.9M in the first nine months of 2019, as contrast to cash provided by operating activities of $4.2M in the first nine months of 2018
KMDA’s shares are at 32.76% for the quarter and driving a 29.27% return over the course of the past year and is now at 0.88% since this point in 2018. The average volatility for the week at 3.19% and for month was at 2.94%. There are 40.51M shares outstanding and 22.07M shares are floated in market.